论文部分内容阅读
门冬胰岛素30注射液(诺和锐30)是一种双时相(预混)人胰岛素类似物,主要成分是30%的可溶性门冬胰岛素和70%的精蛋白门冬胰岛素,此外还含有甘露醇苯酚、间苯酚、氯化钠等成分,是目前临床治疗糖尿病的一种新选择。近年来国内有文献报道,本品可致过敏反应,现概述如下:殷玉剑报道,患男,82岁,因糖尿病给予门冬胰岛素30注射液20U皮下注射,6个月后患者出现注射后
Insulin Aspart 30 Injection (Novo Rui 30) is a dual-phase (premixed) human insulin analogue consisting mainly of 30% soluble aspart insulin and 70% of protamine insulin aspart and, in addition, Mannitol, phenol, sodium chloride and other ingredients, is currently a clinical treatment of diabetes a new choice. In recent years, there are literature reports, this product can cause allergic reactions, are summarized as follows: Yin Yu Jian reported suffering from male, 82 years old, due to diabetes aspart 30 insulin injection 20U subcutaneous injection, 6 months after injection